General Information of This Antibody
Antibody ID
ANI0WPIJG
Antibody Name
Humanized anti PD-L1 SGN-PDL1V mAb
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized IgG
Antigen Name
Programmed cell death 1 ligand 1 (CD274)
 Antigen Info 
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
SGN-PDL1V [Phase 1]
Identified from the Human Clinical Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Related Clinical Trial
NCT Number NCT05208762  Clinical Status Phase 1
Clinical Description
A phase 1 study of SGN-PDL1V in advanced solid tumors.
References
Ref 1 A Phase 1 Study of SGN-PDL1V in Advanced Solid Tumors

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.